PMC · DOI:10.3389/fonc.2024.1411836·April 19, 2024
Editorial: Emerging anti-cancer compounds and immunomodulators for pancreatic cancer treatment
Kathleen E. DelGiorno, Stephen Safe, Jennifer M. Bailey-Lundberg
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases2
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPancreatic and Hepatic Oncology Research · Cancer-related Molecular Pathways · Epigenetics and DNA Methylation